FRE.DE - Fresenius SE & Co. KGaA

XETRA - XETRA Delayed Price. Currency in EUR

Fresenius SE & Co. KGaA

Else-Kröner-Strasse 1
Bad Homburg 61352
Germany
49 6172 608 0
http://www.fresenius.com

SectorHealthcare
IndustryHospitals
Full Time Employees268,508

Key Executives

NameTitlePayExercisedAge
Mr. Stephan SturmCEO of Fresenius Management SE & Chairman of Management Board of Fresenius Management SE2.94MN/A54
Dr. Francesco De MeoMember of the Management Board of Fresenius Management SE and CEO of Fresenius Helios2.17MN/A53
Dr. Jürgen GötzChief Legal & Compliance Officer & Labor Relations Director1.64MN/A53
Dr. Ernst WastlerMember of the Management Board of Fresenius Management SE and CEO of Fresenius Vamed1.48MN/A58
Mr. Mats Christer HenrikssonMember of the Management Board of Fresenius Management SE and CEO of Fresenius Kabi AG2.19MN/A50
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure. This segment offers dialyzers, dialysis machines, and renal pharmaceuticals, as well as dialysis- related services. The Fresenius Kabi segment specializes in the therapy and care of chronically and critically ill patients. This segment offers IV drugs comprising intravenously administered generic anesthetics, analgesics, anti-infectives, and drugs for the treatment of oncological and other critical diseases; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; infusion and nutrition pumps, as well as consumables; and products used in the collection and processing whole blood and blood components, as well as in transfusion medicine. The Fresenius Helios segment operates approximately 112 hospitals, including 88 acute care hospitals and 24 post-acute care clinics; 78 outpatient clinics; 4 out-patient post-acute care centers; 18 prevention centers; and 13 nursing homes. This segment has approximately 35,000 beds. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project development, planning, and turnkey construction services, as well as provides maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg, Germany.

Corporate Governance

Fresenius SE & Co. KGaA’s ISS Governance QualityScore as of October 15, 2017 is 8. The pillar scores are Audit: 1; Board: 7; Shareholder Rights: 1; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.